Physician profile
Muyhong Thy
NPI 1639379894
$705.87
in general payments reported to CMS, 2019-2025
10 companies · $166 in 2025
The $166 reported for 2025 was more than what a typical Dentist provider received nationally (typical 2025 total: $70.27).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $114 · 2020: $105 · 2022: $154 · 2023: $142 · 2024: $25.40 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Gift: $203 · Food and Beverage: $74.74 · Education: $55.58.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Gift | $202.98 |
| Food and Beverage | $74.74 |
| Education | $55.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ultradent Products INC | $326.53 | 2019-2025 | Opalescence |
| 3m Company | $113.36 | 2022 | |
| Align Technology, INC. | $81.44 | 2022-2023 | Invisalign, Itero |
| Zimmer Biomet Holdings, INC. | $75.00 | 2020 | |
| Hu-Friedy Mfg. Co., LLC | $30.00 | 2020 | |
| Dentsply Sirona INC | $19.70 | 2023 | Palodent Plus Ez Coat Sectional Matrix System |
| Solventum Corporation | $15.84 | 2024 | 3m Filtek, Filtek, 3m Relyx |
| Philips North America LLC | $15.78 | 2025 | Whitening Pens |
| Gc America INC. | $14.36 | 2022 | |
| Colgate Oral Pharmaceuticals, INC. | $13.86 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muyhong Thy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.